Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Greenblatt

Showing results (1-10 of 869) with videos related to

Pageof 87
Sort By:
Hospital Practice (Office Ed.)|June 1, 1990
Pharmacokinetics and pharmacodynamicsD J Greenblatt
Journal of Clinical Psychopharmacology|October 1, 1987
Could you please review what is currently known about drug half-life and efficacy in light of recent advances in receptor theory?D J Greenblatt
IMJ. Illinois Medical Journal|August 1, 1971
Toward the rational use of digoxinD J Greenblatt
The Journal of Clinical Psychiatry|September 1, 1991
Benzodiazepine hypnotics: sorting the pharmacokinetic factsD J Greenblatt
Annual Review of Medicine|January 1, 1985
Elimination half-life of drugs: value and limitationsD J Greenblatt
Lancet (London, England)|December 18, 1971
Urinary-tract infection and low-dose nitrofurantoinD J Greenblatt
Annual Review of Pharmacology and Toxicology|January 1, 1979
Predicting steady state serum concentrations of drugsD J Greenblatt
Journal of Clinical Pharmacology|November 15, 2000
Academic perspectives on the MTD: pharmacodynamic end points: maximizing the value of MTD studiesD J Greenblatt
Clinical Pharmacokinetics|March 1, 1981
Clinical pharmacokinetics of oxazepam and lorazepamD J Greenblatt
Journal of the American Geriatrics Society|January 1, 1979
Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance ProgramD J Greenblatt
Pageof 87

Showing results (1-10 of 869) with videos related to

Sort By:
Pageof 87
Hospital Practice (Office Ed.)|June 1, 1990
Pharmacokinetics and pharmacodynamicsD J Greenblatt
Journal of Clinical Psychopharmacology|October 1, 1987
Could you please review what is currently known about drug half-life and efficacy in light of recent advances in receptor theory?D J Greenblatt
IMJ. Illinois Medical Journal|August 1, 1971
Toward the rational use of digoxinD J Greenblatt
The Journal of Clinical Psychiatry|September 1, 1991
Benzodiazepine hypnotics: sorting the pharmacokinetic factsD J Greenblatt
Annual Review of Medicine|January 1, 1985
Elimination half-life of drugs: value and limitationsD J Greenblatt
Lancet (London, England)|December 18, 1971
Urinary-tract infection and low-dose nitrofurantoinD J Greenblatt
Annual Review of Pharmacology and Toxicology|January 1, 1979
Predicting steady state serum concentrations of drugsD J Greenblatt
Journal of Clinical Pharmacology|November 15, 2000
Academic perspectives on the MTD: pharmacodynamic end points: maximizing the value of MTD studiesD J Greenblatt
Clinical Pharmacokinetics|March 1, 1981
Clinical pharmacokinetics of oxazepam and lorazepamD J Greenblatt
Journal of the American Geriatrics Society|January 1, 1979
Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance ProgramD J Greenblatt
Pageof 87